SUPERIOR GROUP OF COMPANIES, INC. — Form 8-K
Filed August 4, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 28/100
What the filing says
Superior Group reported Q2 2026 net sales of $147.8M (up from $144.0M in Q2 2025, +2.6%). Reported net income fell to $1.2M ($0.08/share) from $1.6M ($0.10/share) due to a $2.6M non-cash tradename impairment in Healthcare Apparel segment. Adjusted EBITDA increased to $7.7M from $6.1M; adjusted EPS was $0.21 vs. $0.10 prior year. Board approved $0.14/share quarterly dividend. Full-year 2026 guidance unchanged: $572–$585M sales, $0.54–$0.66 adjusted EPS.
Why this rating
Modest 2.6% sales growth and non-cash write-down offset by improved adjusted metrics. Impairment is small relative to $116M market cap; no cash/covenant impact. Routine quarterly disclosure.
See more from August 4, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.